Noveris Health Sciences MYCOF Stock
Noveris Health Sciences Price Chart
Noveris Health Sciences MYCOF Financial and Trading Overview
| Noveris Health Sciences stock price | 2 USD |
| Previous Close | 2 USD |
| Open | 2 USD |
| Bid | 2 USD x 0 |
| Ask | 1.95 USD x 0 |
| Day's Range | 2 - 2 USD |
| 52 Week Range | 0.03 - 2.04 USD |
| Volume | 400 USD |
| Avg. Volume | 498 USD |
| Market Cap | 117.1M USD |
| Beta (5Y Monthly) | -5.484 |
| PE Ratio (TTM) | 1.1173185 |
| EPS (TTM) | 1.77 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MYCOF Valuation Measures
| Enterprise Value | 115.49M USD |
| Trailing P/E | 1.1173185 |
| Forward P/E | 0.8 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Noveris Health Sciences Stock Price History
| Beta (5Y Monthly) | -5.484 |
| 52-Week Change | 1233.33% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 2.04 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 1.31 USD |
| 200-Day Moving Average | 0.55 USD |
MYCOF Share Statistics
| Avg. Volume (3 month) | 498 USD |
| Avg. Daily Volume (10-Days) | 50 USD |
| Shares Outstanding | 58.55M |
| Float | 58.52M |
| Short Ratio | N/A |
| % Held by Insiders | 0.050% |
| % Held by Institutions | 6.57% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -27.50% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | 1.6M USD |
| Diluted EPS (ttm) | 1.79 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.03M USD |
| Total Cash Per Share (mrq) | 0.04 USD |
| Total Debt (mrq) | 424.27K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.472 |
| Book Value Per Share (mrq) | -0.026822908 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -283922 USD |
| Levered Free Cash Flow (ttm) | -4672687 USD |
Profile of Noveris Health Sciences
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 1075 West Georgia Street |
| ZIP | V6E 3C9 |
| Phone | 778 900 6877 |
| Website | https://noveris.health |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Noveris Health Sciences Inc., a biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Noveris Health Sciences Inc. was formerly known as Mydecine Innovations Group Inc. and changed its name to Noveris Health Sciences Inc. in February 2026. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Q&A For Noveris Health Sciences Stock
What is a current MYCOF stock price?
Noveris Health Sciences MYCOF stock price today per share is 2 USD.
How to purchase Noveris Health Sciences stock?
You can buy MYCOF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Noveris Health Sciences?
The stock symbol or ticker of Noveris Health Sciences is MYCOF.
Which industry does the Noveris Health Sciences company belong to?
The Noveris Health Sciences industry is Drug Manufacturers - Specialty & Generic.
How many shares does Noveris Health Sciences have in circulation?
The max supply of Noveris Health Sciences shares is 58.55M.
What is Noveris Health Sciences Price to Earnings Ratio (PE Ratio)?
Noveris Health Sciences PE Ratio is 1.12994350 now.
What was Noveris Health Sciences earnings per share over the trailing 12 months (TTM)?
Noveris Health Sciences EPS is 1.77 USD over the trailing 12 months.
Which sector does the Noveris Health Sciences company belong to?
The Noveris Health Sciences sector is Healthcare.